<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02671838</url>
  </required_header>
  <id_info>
    <org_study_id>US-01-2016</org_study_id>
    <nct_id>NCT02671838</nct_id>
  </id_info>
  <brief_title>A Musculoskeletal Ultrasound Program to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis</brief_title>
  <official_title>Developing a Musculoskeletal Ultrasound Program as an Intervention to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-adherence to medications can lead to sub-optimal treatment in rheumatoid arthritis (RA)&#xD;
      patients. In order to improve disease modifying anti-rheumatic drugs (DMARDs) adherence, the&#xD;
      investigators are conducting a randomized controlled trial to test out an intervention to&#xD;
      improve medications adherence among low adherers. This intervention involves the use of a&#xD;
      musculoskeletal ultrasound program which allows RA patients to visualize their joint&#xD;
      inflammation and damage real time while treatment adherence is simultaneously reinforced. In&#xD;
      doing so, the investigators hope to improve patients' understanding of their joint disease&#xD;
      and motivate the participants to adhere to their medications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center randomized controlled clinical trial conducted in the Singapore&#xD;
      General Hospital. Eligible RA subjects meeting the inclusion and exclusion criteria will be&#xD;
      screened using a medication adherence measure questionnaire. Thereafter 132 patients who are&#xD;
      low adherers on the questionnaire will then be recruited and randomized (in a 1:1 ratio) to&#xD;
      either (a) intervention arm (with musculoskeletal US program) or (b) control arm (without&#xD;
      musculoskeletal US program), and followed up over a period of about 6 month.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">October 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in proportion of patients with a low adherence score using medication adherence measure (questionnaire)</measure>
    <time_frame>baseline and 1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in proportion of patients with a low adherence score using medication adherence measure (questionnaire)</measure>
    <time_frame>baseline, 3 months and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in proportion of patients with a low adherence score using medication adherence measure (pharmacy dispense data)</measure>
    <time_frame>baseline, 1 month, 3months and 6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in clinical follow-up defaults (e.g. how often patients do not show up for their clinic appointments)</measure>
    <time_frame>baseline, 3 months and 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in clinical joint assessment outcomes(e.g. disease activity score 28)</measure>
    <time_frame>baseline, 3 months and 6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Musculoskeletal ultrasound program</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participants will receive the musculoskeletal ultrasound program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will not be receiving the musculoskeletal ultrasound program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Musculoskeletal ultrasound program</intervention_name>
    <description>Using a musculoskeletal ultrasound program to help improve medication adherence</description>
    <arm_group_label>Musculoskeletal ultrasound program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male and female patients from 21 to 75 years old&#xD;
&#xD;
          -  Underlying rheumatoid arthritis diagnosed using the 1987 or 2010 RA criteria&#xD;
&#xD;
          -  On at least one of the following DMARDs (Methotrexate, Sulfasalazine,&#xD;
             Hydroxychloroquine and/or Leflunomide)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>January 26, 2016</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2016</study_first_posted>
  <last_update_submitted>October 25, 2020</last_update_submitted>
  <last_update_submitted_qc>October 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

